Arcus Biosciences, Inc. RCUS
18.02 USD -0.17 -0.93%
As of Nov 2, 11:59 AM ET
17.43 52-week range 31.74
- YTD
- -24.38%
- 1 year
- -8.62%
- Open
- 18.23
- Prev close
- 18.19
- Mkt cap
- 2.27B
- Vol
- 334.74K
- Avg vol
- 1.81M
- EPS
- -3.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.76
- High
- 18.49
- Forward P/E
- -5.84
- Beta
- 0.94
- Short ratio
- 8.16
- Inst. own
- 66.38%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 25.20
- 200-d avg
- 24.70
- 1y target
- 41.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for RCUS has not been loaded yet. Try again in a moment.
Altman Z-Score
-0.28 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
P/E -7.2×
P/S 10.4×
P/B 4.1×
P/FCF -5.3×
EV/EBITDA -7.3×
EV/Sales 9.9×
FCF Yield -18.9%
Gross Margin 96.0%
Operating Margin -156.3%
Net Margin -142.9%
ROE -55.9%
ROIC -41.9%
ROA -31.0%
Revenue -4.3%
Operating Income -17.0%
EPS (diluted) -4.8%
Free Cash Flow -175.0%
Current Ratio 4.4×
Quick Ratio 4.4×
Debt / Equity 0.2×
Net Debt / EBITDA 0.3×
Interest Coverage -48.3×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31